Cargando…
Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma
Introduction: Hepatocellular carcinoma (HCC) typically develops in cirrhotic livers, with increased programed death ligand 1 (PD-L1) and transforming growth factor beta (TGF-β) activity implicated in immunosuppression. Methods: In an observational study of HCC liver samples, we determined the incide...
Autores principales: | Ihling, Christian, Naughton, Bartholomew, Zhang, Yue, Rolfe, P. Alexander, Frick-Krieger, Eveline, Terracciano, Luigi M., Dussault, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375852/ https://www.ncbi.nlm.nih.gov/pubmed/30800658 http://dx.doi.org/10.3389/fmed.2019.00015 |
Ejemplares similares
-
Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020) -
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment
por: Gulley, James L., et al.
Publicado: (2022) -
Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1
por: Vugmeyster, Yulia, et al.
Publicado: (2020) -
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
por: Ng, Charlotte K. Y., et al.
Publicado: (2018) -
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
por: Tan, Benjamin, et al.
Publicado: (2021)